These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 11365909

  • 1. Off label drug promotion.
    Body Posit; 1998 Oct; 11(10):11. PubMed ID: 11365909
    [Abstract] [Full Text] [Related]

  • 2. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL, Katz KA.
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [Abstract] [Full Text] [Related]

  • 3. Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
    Joseph JN, Deaton D, Ehsan H, Bonanno MA.
    J Health Life Sci Law; 2009 Jan; 2(2):73-108. PubMed ID: 19288889
    [Abstract] [Full Text] [Related]

  • 4. The regulation of prescription drug advertising.
    Rheinstein RH, Hugstad PS.
    Leg Med Annu; 1978 Jan; ():407-19. PubMed ID: 756944
    [No Abstract] [Full Text] [Related]

  • 5. Direct-to-consumer advertising--education or emotion promotion?
    Wolfe SM.
    N Engl J Med; 2002 Feb 14; 346(7):524-6. PubMed ID: 11844857
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J.
    Food Drug Law J; 2003 Feb 14; 58(4):629-48. PubMed ID: 15027454
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The new drug marketing: a consumer protection perspective.
    Woodward D.
    Food Drug Law J; 1996 Feb 14; 51(4):637-50. PubMed ID: 11797733
    [No Abstract] [Full Text] [Related]

  • 11. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA.
    Issue Brief Health Policy Track Serv; 2009 Jan 05; ():1-28. PubMed ID: 19297718
    [No Abstract] [Full Text] [Related]

  • 12. Origins of the prohibition against off-label promotion.
    Coleman TS.
    Food Drug Law J; 2014 Jan 05; 69(2):161-236, i. PubMed ID: 25163210
    [Abstract] [Full Text] [Related]

  • 13. Plugs for drugs.
    Masson A, Rubin PH.
    Regulation; 1986 Jan 05; 10(1):37-43, 53. PubMed ID: 10280556
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS.
    Food Drug Law J; 1996 Jan 05; 51(3):355-65. PubMed ID: 11797712
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Children on losing end of access to new drugs.
    AIDS Alert; 1998 Jan 05; 13(1):10-2. PubMed ID: 11364862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.